Infection Surveillance Solutions Market to Reach USD 1.60 Billion by 2029 as Hospitals Accelerate Digital Infection Prevention

Market Estimation, Growth Drivers, and Opportunities

The global Infection Surveillance Solutions Market was valued at USD 588.54 million in 2022 and is projected to reach USD 1,604.05 million by 2029, registering a compound annual growth rate (CAGR) of 15.4% during the 2023–2029 forecast period. Growing concerns about healthcare-associated infections (HAIs), antimicrobial resistance, and patient safety are encouraging hospitals to adopt digital surveillance systems.

Infection surveillance solutions help healthcare providers collect, analyze, and monitor patient data to identify infections, detect emerging trends, and support timely intervention. These systems can integrate electronic health records (EHRs), laboratory results, pharmacy data, and clinical documentation to identify potential infections and support infection prevention teams. Rising hospital admissions, surgical procedures, chronic diseases, and an aging population are strengthening demand for automated surveillance.

Technology innovation is creating opportunities for vendors offering artificial intelligence (AI), predictive analytics, automated reporting, and cloud-based platforms. These tools can reduce manual data collection, improve identification of high-risk patients, and help hospitals monitor infection patterns across departments. Growing attention to antimicrobial stewardship and regulatory reporting is also supporting investment. However, implementation costs, data privacy concerns, and integration challenges remain important barriers, particularly for smaller healthcare facilities.

* Get Actionable Market Insights: https://www.maximizemarketresearch.com/request-sample/5497/ 

US Market Trends and Investment in 2025

The United States remained an important market in 2025 as hospitals increasingly emphasized infection prevention, automated reporting, and AI-supported clinical surveillance. A significant regulatory development involved the Centers for Medicare & Medicaid Services' Promoting Interoperability Program, which separated antimicrobial use and antimicrobial resistance surveillance into two measures for the 2025 reporting period. This increased the importance of reliable electronic data collection and reporting through the CDC's National Healthcare Safety Network. In September 2025, Cleveland Clinic announced plans to expand its deployment of Bayesian Health's AI-enabled clinical intelligence platform across its US hospitals to support earlier sepsis detection and treatment. Although sepsis detection is broader than infection surveillance, the initiative demonstrates growing healthcare investment in AI tools that identify clinical deterioration and infection-related risks. These developments create opportunities for surveillance vendors to strengthen EHR integration, automate reporting, and deliver actionable alerts that support patient safety. 

Market Segmentation: Largest Market Shares

By product type, infection surveillance software solutions held the largest market share in 2022. Hospitals increasingly use software to track healthcare-associated infections, analyze patient records, and support timely infection-control decisions. Automated surveillance can help clinical teams identify potential infection events while reducing the administrative burden associated with manual monitoring.

By region, North America held the largest share of the global market. The report estimates that the United States accounted for approximately 35.26% of the global market in 2022. Advanced healthcare IT infrastructure, established infection-reporting systems, and growing investment in patient safety contribute to regional leadership.

Key Players are:
1. Vecna Technologies, Inc. (US)
2. Becton, Dickinson and Company (US)
3. Sunquest (US)
4. Wolters Kluwer N.V. (Netherlands)
5. Cerner Corporation (US)
6. Premier, Inc. (US)
7. GOJO Industries, Inc. (US)
8. Deb Group Ltd. (UK)
9. Baxter International Inc. (US)
10.BioMerieux SA (France)
11.BioVigil Healthcare Systems (US)
12.RLDatix (UK)
13.CKM Healthcare (Canada)
14.IBM Corporation (US)
15.PeraHealth Inc. (US)
16.Ecolab Inc. (US)
17.VigiLanz Corporation (US)
18.Medexter Healthcare (Austria)
19.CenTrak, Inc. (US)
20.Asolva Inc. (US)
21.PointClickCare (Canada)
22.Harris Healthcare (US)
23.Vitalacy Inc. (US)
24.STANLEY Healthcare (US)
25.Vizzia Technologies (US)

Competitive Analysis: Key Companies

The market report identifies several major participants, including Becton, Dickinson and Company, Wolters Kluwer N.V., Cerner Corporation, Premier, Inc., and bioMérieux SA.

• Becton, Dickinson and Company (BD): Its HealthSight Infection Advisor with MedMined Insights supports healthcare-associated infection surveillance, analytics, and near-real-time alerts to help infection prevention teams identify risks.
• Wolters Kluwer N.V.: Its Sentri7 Infection Prevention platform integrates with EHR systems, provides real-time alerts, and supports surveillance analytics and reporting.
• Cerner Corporation: Now part of Oracle Health, its healthcare information technology ecosystem supports the integration of clinical records and data-driven hospital workflows.
• Premier, Inc.: Its PINC AI Clinical Surveillance solutions help healthcare providers monitor infection-related conditions, automate alerts, and support reporting workflows.
• bioMérieux SA: Its diagnostic testing and microbiology expertise supports infection detection and antimicrobial resistance monitoring, complementing the data required for infection prevention and surveillance.

Competition increasingly centers on interoperability, automated data extraction, AI-supported risk identification, and simplified regulatory reporting. Vendors that integrate effectively with existing hospital systems can help healthcare providers improve efficiency without adding unnecessary administrative work. 

Regional Analysis: United States, United Kingdom, Germany, France, Japan, and China

United States: Federal reporting programs, advanced hospital IT infrastructure, and demand for measurable patient-safety improvements support market adoption.

United Kingdom: National infection prevention priorities and digital healthcare initiatives create opportunities for systems that improve surveillance, reporting, and outbreak detection.

Germany: Strong healthcare infrastructure and concern about antimicrobial resistance support demand for reliable clinical data integration and infection monitoring.

France: Hospital modernization and infection-control initiatives encourage adoption of digital surveillance and reporting tools.

Japan: An aging population, advanced healthcare technology, and the need to improve hospital efficiency support investment in automated monitoring.

China: Expanding healthcare infrastructure, a large patient population, and increasing attention to hospital quality create opportunities for infection surveillance software.

Country-specific market-share figures for the UK, Germany, France, Japan, and China are not provided in the report's public summary.

Related Reports: 

Global Local Anesthesia Drugs Market https://www.maximizemarketresearch.com/market-report/global-local-anesthesia-drugs-market/106101/ 
North America Blood Glucose Monitoring System Market https://www.maximizemarketresearch.com/market-report/blood-glucose-monitoring-system-market-north-america/1638/ 
Autologous Matrixinduced Chondrogenesis Market https://www.maximizemarketresearch.com/market-report/autologous-matrix-induced-chondrogenesis-market/37118/ 

Conclusion

The Infection Surveillance Solutions Market is positioned for strong growth as healthcare providers prioritize patient safety, antimicrobial stewardship, and data-driven infection prevention. In my view, AI-powered surveillance, automated reporting, and seamless EHR integration represent the most significant opportunities. Vendors that deliver accurate alerts, protect sensitive patient data, and reduce administrative workloads can help hospitals strengthen infection-control programs while improving operational efficiency.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com